Effectiveness of paravertebral block in patients with herpes zoster according to the contrast spreading pattern: a retrospective cohort study
Abstract
Objectives This study aims to evaluate the treatment response to thoracic paravertebral block (PVB) in thoracic herpes zoster (HZ) pain based on the contrast spreading pattern. Methods Patients with HZ pain who underwent thoracic PVB under fluoroscopy were retrospectively analyzed. A comparative analysis of the treatment response was conducted between patients with epidural spread (ES group) and those without epidural spread (NES group) at the first visit after PVB. The treatment response was determined by setting the minimum clinically important difference (MCID) as a reduction of more than 1 point on the pain numerical rating scale (NRS). In addition, the treatment responses were compared according to prevertebral spread, intercostal spread, and segmented medial spread (base, foraminal, and subarticular-central spread). The NRS score was assessed at baseline and 3 days, 2 weeks, 1 and month after PVB. Generalized estimating equation (GEE) analysis was performed to identify the factors associated with the treatment response over time. Results In total, 48 patients were enrolled (ES, n = 21; NES, n = 27). The ES group had a higher proportion of patients with the treatment response than the NES group (p = 0.025). However, there was no significant difference in the treatment response according to prevertebral, intercostal, and segmented medial spread. In both groups, the mean NRS scores significantly decreased over time. Comparisons between groups at each time point were not…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 48 participants or records.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.